|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.59 USD | +0.58% |
|
-1.09% | -32.08% |
| 05-07 | Needham Cuts Price Target on Azenta to $33 From $44, Keeps Buy Rating | MT |
| 05-06 | Azenta, Inc., Q2 2026 Earnings Call, May 06, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.04B | - | - | - | ||
| 42.96B | |||||
| 31.73B | - | - | - | - | - |
| 30.22B | |||||
| 28.94B | |||||
| 23.87B |
- Stock Market
- Stocks
- AZTA Stock
- Charts Azenta, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
